Pharmaceutical industry -- United States

See also what's at your library, or elsewhere.

• Pharmaceutical industry
• Chemical industry -- United States
• United States

• Pharmaceutical industry -- United States -- Capital productivity
• Pharmaceutical industry -- United States -- Directories
• Pharmaceutical industry -- United States -- Employees
• Pharmaceutical industry -- United States -- Management
• Pharmaceutical industry -- United States -- Prices
• Pharmaceutical industry -- United States -- Quality control
• Pharmaceutical industry -- United States -- Statistics
• Pharmaceutical industry -- United States -- Technological innovations
• Dietary supplements industry -- United States
• Drug packaging industry -- United States
• Nonprescription drug industry -- United States
• Vaccines industry -- United States
• Pharmaceutical industry -- Michigan
• Pharmaceutical industry -- New York (State)
• Pharmaceutical industry -- Ohio
• Pharmaceutical industry -- Rhode Island
• Advertising -- Pharmaceutical industry -- Law and legislation -- United States
• Pharmaceutical industry -- Corrupt practices -- United States
• Pharmaceutical industry -- Environmental aspects -- United States
• Pharmaceutical industry -- Government policy -- United States
• Pharmaceutical industry -- Research -- United States
• Pharmaceutical industry -- Security measures -- United States
• Pharmaceutical industry -- Standards -- United States
• Pharmaceutical industry -- Taxation -- United States
• Pharmaceutical industry -- Technological innovations -- United States

• Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI)
• Threescore Years and Ten: A Narrative of the First Seventy Years of Eli Lilly and Company, 1876-1946 (Chicago: Lakeside Press, 1946), by Roscoe Collins Clark (page images at HathiTrust)
• The Distribution of illegal incident characteristics : cases of bank fraud and embezzlement, computer-related crime, and insider theft from drug manufacturers and distributors / J.M. Heineke and Associates ; prepared for SAFER, U.S. Nuclear Regulatory Commission. (Washington, D.C. : The Commission : Available from GPO Sales Program, Division of Technical Information and Document Control, U.S. Nuclear Regulatory Commission ; Springfiled, Va. : National Technical Information Service, 1980) (page images at HathiTrust)
• User fees for prescription drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
• The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1993. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993), by United States. Congress. Senate. Special Committee on Aging (page images at HathiTrust)
• Prescription drugs : companies typically charge more in the United States than in the United Kingdom : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives / United States General Accounting Office. (Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1994]), by United States General Accounting Office (page images at HathiTrust)
• Competitive problems in the drug industry Federal drug procurement and purchase policies, summary and analysis : [prepared for] Select Committee on Small Business, United States Senate, Subcommittee on Monopoly / prepared by Congressional Research Service, Library of Congress ; [by Glenn R. Markus and Jack Ebeler]. (Washington : U.S. Gov. Print. Off., 1974), by Library of Congress. Education and Public Welfare Division (page images at HathiTrust)
• Administered prices: drugs. (Washington, U. S. Govt. Print. Off., 1961), by United States Senate Committee on the Judiciary (page images at HathiTrust)
• Is the doctor in? (New York, Exposition Press, [1963]), by Rufus L. McQuillan (page images at HathiTrust)
• Competition in the drug industry hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, first session, March 10, 1981. (Washington : U.S. G.P.O., 1981), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
• "Man-in-the-plant" revisited, a deceptive drug labeling practice continues hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Committee, House of Representatives, Ninety-sixth Congress, second session, March 6, 1980. (Washington : U.S. Govt. Print. Off., 1980), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
• Drug regulation reform--oversight hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session .... (Washington : U.S. G.P.O., 1980-), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
• Census of American business : 1933. A civil works administration project. Retail distribution. Drug retailing including drug-store chains. May, 1935. ([Washington, 1935]), by United States. Bureau of the Census (page images at HathiTrust)
• The basis and development of fair trade; (New York, [1946]), by National Wholesale Druggists' Association (page images at HathiTrust)
• Pharmacy benefit managers : FEHBP plans satisfied with savings and services, but retail pharmacies have concerns : report to Congressional requesters / United States General Accounting Office. (Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1997]), by United States General Accounting Office (page images at HathiTrust)
• Pharmaceutical industry : hazardous waste generation, treatment, and disposal. ([Washington] ; U.S. Environmental Protection Agency, 1976), by United States. Environmental Protection Agency (page images at HathiTrust)
• Economic report on antibiotics manufacture, June 1958. (Washington, U. S. Govt. Print. Off., 1958), by United States Federal Trade Commission (page images at HathiTrust)
• A Competitive assessment of the U.S. pharmaceutical industry / prepared by Industry Analysis Division. (Washington, D.C. : U.S. Dept. of Commerce, International Trade Administration : For sale by the Supt. of Docs., U.S. G.P.O., 1985) (page images at HathiTrust)
• Federal strategy for prevention of drug abuse and drug trafficking, 1982 / prepared for the President pursuant to the Drug Abuse Office and Treatment Act of 1972. ([Washington, D.C.] : Drug Abuse Policy Office, Office of Policy Development, the White House : For sale by the Supt. of Docs., U.S. G.P.O., [1982?]), by United States. Office of Drug Abuse Policy (page images at HathiTrust)
• A plan for action : phase II. (Rockville, Md. : U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, [1987]), by United States. Food and Drug Administration (page images at HathiTrust)
• Competitive problems in the drug industry drug testing : summary and analysis / Select Committee on Small Business, United States Senate / prepared by the Congressional Research Service, Library of Congress ; [prepared by Janet E. Lemke ; edited by Vikki Zegel]. (Washington : U.S. Govt. Print. Off., 1979), by Library of Congress. Congressional Research Service (page images at HathiTrust)
• 1992 census of manufactures. (Washington DC : U.S. Dept. of Commerce, Economics and Statistics Administration, Bureau of the Census : For sale by Supt. of Docs., U.S. G.P.O., [1995]), by Census of manufactures (1992) (page images at HathiTrust)
• CDER ... report to the nation / Center for Drug Evaluation and Research. (Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 1998-), by Center for Drug Evaluation and Research (U.S.) (page images at HathiTrust)
• From test tube to patient : new drug development in the United States. (Rockville, MD : Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, [1988]) (page images at HathiTrust)
• Prescription drug diversion and counterfeiting : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first-[second] session. (Washington : U.S. G.P.O., 1986-1987), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
• Traffic in narcotic drugs. (Washington, Govt. print. off., 1919), by United States. Dept. of the Treasury. Special narcotic committee (page images at HathiTrust)
• Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985. (Washington : U.S. G.P.O., 1986), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
• Prescription drug programs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992) (page images at HathiTrust)
• Earning a failing grade : a report card on 1992 drug manufacturer price inflation : staff report to the Special Committee on Aging, United States Senate. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993) (page images at HathiTrust)
• Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004), by United States Senate Committee on Commerce, Science, and Transportation (page images at HathiTrust)
• Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Tenth Congress, first session, special hearing, June 1, 2007, Salt Lake City, Utah. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008), by Rural Development United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture (page images at HathiTrust)
• Rx for generic drug safety : accurate information for older Americans : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, March 1, 1990. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 1990), by United States. Congress. House. Select Committee on Aging. Subcommittee on Housing and Consumer Interests (page images at HathiTrust)
• Proceedings. (New York [etc.] National Wholesale Druggists' Association.), by National Wholesale Druggists' Association (page images at HathiTrust; US access only)
• Pricing of drugs, 1977 joint hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources and the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, 95th Congress, first session ... July 14, 1977. (Washington : U.S. Govt. Print. Off., 1977), by United State Senate Subcommittee on Health and Scientific Research (page images at HathiTrust)
• High drug costs for the elderly the need for relief : hearing before the Subcommittee on Human Services of the Select Committee on Aging, House of Representatives, Ninety-eighth Congress, second session, September 10, 1984, Bronx, NY. (Washington : U.S. G.P.O., 1984), by United States. Congress. House. Select Committee on Aging. Subcommittee on Human Services (page images at HathiTrust)
• Drug Price Competition and Patent Term Restoration Act of 1984 hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-eighth Congress, second session on S. 2748 ... June 28, 1984. (Washington : U.S. G.P.O., 1984), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
• User fees for prescription drugs hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992. (Washington : U.S. G.P.O., 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
• Prescription drug price increases hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985. (Washington : U.S. G.P.O., 1986), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
• Census of business; 1935. ([Washington, 1937]), by United States. Bureau of the Census (page images at HathiTrust)
• Interim report[s] (Washington, Office of the Secretary, U.S. Dept. of Health, Education and Welfare, 196-), by United States. Task Force on Prescription Drugs (page images at HathiTrust)
• Perspectives on pharmaceutical pricing practices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996), by United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
• Proceedings of... annual meeting ([New York?]), by American Drug Manufacturers Association (page images at HathiTrust)
• Food and drug act amendment, relating to exports. Hearings, Eighty-first Congress, first session on H.R. 562. July 25 and August 8, 1950. (Washington, U. S. Govt. Print. Off., 1950), by United States. Congress. Senate. Committee on Interstate and Foreign Commerce (page images at HathiTrust)
• Drug pricing : poor prescription for consumers and taxpayers? : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Third Congress, second session, July 27, 1994. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1995), by United States Senate Committee on Governmental Affairs (page images at HathiTrust)
• Preclinical and clinical testing by the pharmaceutical industry, 1975- : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, first session- on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out. (Washington : U. S. Govt. Print. Off., 1975-), by United States. Congress. Senate. Committee on Labor and Public Welfare (page images at HathiTrust)
• The professional pharmacy; an analysis of prescription department activities; part of the national drug store survey. ([Washington] American Pharmaceutical Assn., 1935), by Frank Anthony Delgado (page images at HathiTrust)
• Establishments and products licensed under section 351 of the Public Health Service Act / U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration. (Bethesda, Md. : The Administration,) (page images at HathiTrust)
• Competitive problems in the drug industry hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session ... (Washington : U.S. Govt. Print. Off., 1967-), by United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and Anticompetitive Activities (page images at HathiTrust)
• Competitive problems in the pharmaceutical drug industry hearing before the Subcommittee on Antitrust, Monopolies [sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987. (Washington : U.S. G.P.O., 1989), by Monopoly United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust (page images at HathiTrust)
• FDA interim index to evaluations published in the Federal register for NAS-NRC reviewed prescription drugs. (Rockville, Md. : U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Bureau of Drugs.), by United States. Food and Drug Administration. Drug Efficacy Study Implementation Project (page images at HathiTrust)
• Competitive problems in the drug industry fixed-dose combination antibiotic drugs : summary and analysis / Select Committee on Small Business, United States Senate, Subcommittee on Monopoly, Economic Concentration, and Anticompetitive Activities ; prepared by the Congressional Research Service, Library of Congress ; [prepared by RenSee Ford ; edited by Vikki Zegel]. (Washington : U.S. Govt. Print. Off., 1979), by Library of Congress. Congressional Research Service (page images at HathiTrust)
• User fees for the Food and Drug Administration : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second session, on examining proposed legislation to authorize the Food and Drug Administration to charge user fees to prescription drug manufacturers to increase resources to improve the review time on drug applications, September 22, 1992. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
• Skyrocketing prescription drug prices : hearings before the Special Committee on Aging, United States Senate, One Hundred First Congress, first session, Washington, DC ... July 18, 1989 ... November 16, 1889. (Washington : U.S. G.P.O. : For sale by the Supt. of Doc., Congressional Sales Office, U.S. G.P.O., 1990), by United States. Congress. Senate. Special Committee on Aging (page images at HathiTrust)
• Pharmaceutical marketplace reform : is competition the right prescription? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, November 16, 1993. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994), by United States. Congress. Senate. Special Committee on Aging (page images at HathiTrust)
• Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007), by United States Senate Committee on the Judiciary (page images at HathiTrust)
• A Status report, accessibilty and affordability of prescription drugs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992) (page images at HathiTrust)
• A Status report, accessibility and affordability of prescription drugs for older Americans (annotated) : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992) (page images at HathiTrust)
• The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1992. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993), by United States. Congress. Senate. Special Committee on Aging (page images at HathiTrust)
• The licit importation of opium : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred First Congress, second session, February 27, 1990. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, 1990), by United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime (page images at HathiTrust)
• FDA Export Reform and Enhancement Act of 1995 : hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1995), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Aging (page images at HathiTrust)
• Drug Price Competitition and Patent Term Restoration Act of 1984 : hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-eighth Congress, second session on S. 2748 ... June 28, 1984. (Washington : U.S. G.P.O., 1984), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
• U.S. international trade performance and outlook : competitive position in the automotive, aerospace, and chemical and pharmaceutical sectors : hearings before the Subcommittee on Trade of the Committee on Ways and Means, House of Representatives, One Hundred Second Congress, second session, March 11, 23, 30, 31; and April 7, 1992. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Trade (page images at HathiTrust)
• Oversight of the Food and Drug Administration's progress in reducing unnecessary paperwork burdens upon small business : hearing before the Subcommittee on Government Programs of the Committee on Small Business, House of Representatives, One Hundred Fourth Congress, second session, Washington, DC, July 24, 1996. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996 [i.e. 1997]), by United States. Congress. House. Committee on Small Business. Subcommittee on Government Programs (page images at HathiTrust)
• Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry / The Congress of the United States, Congressional Budget Office ; [written by Anna Cook under the supervision of Jan Paul Acton and Elliot Schwartz]. ([Washington, D.C.] : The Office, [1998]), by Anna Cook (page images at HathiTrust)
• International trade and pharmaceuticals : joint hearing before the Subcommittee on International Trade and the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, April 27, 2004. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004), by United States. Congress. Senate. Committee on Finance. Subcommittee on International Trade (page images at HathiTrust)
• How to improve the procurement and supply of drugs in the Federal Government; report to the Congress [on the] Department of Defense, Veterans Administration, Department of Health, Education, and Welfare, Office of Management and Budget [and] General Services Administration, by the Comptroller General of the United States. ([Washington, 1973]), by United States General Accounting Office (page images at HathiTrust)
• Prescription drugs : changes in prices for selected drugs : report to Congressional requesters / United States General Accounting Office. (Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20877) : The Office [distributor, 1992]), by United States General Accounting Office (page images at HathiTrust)
• Prescription drug prices : analysis of Canada's Patented Medicine Prices Review Board : report to the Chairman, Special Committee on Aging, U.S. Senate / United States General Accounting Office. (Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20877) : The Office [distributor, 1993]), by United States General Accounting Office (page images at HathiTrust)
• Vitamin, mineral, and diet supplements. Prepared by the staff. October 1973. (Washington : U.S. Govt. Print. Off., 1973), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Public Health and Environment (page images at HathiTrust)
• Wages and hours in drugs and medicines and in certain toilet preparations, by Arthur T. Sutherland. (Washington, U.S. Govt. Print. Off., 1939), by Arthur T. Sutherland (page images at HathiTrust)
• In the matter of doxycycline : investigation no. 337-TA-3. (Washington, D.C. : U.S. International Trade Commission, [1979]), by United States International Trade Commission (page images at HathiTrust)
• Furazolidone / United States Tariff Commission. (Washington : The Commission, 1969), by United States Tariff Commission (page images at HathiTrust)
• Economic report [on] sales, promotion, and product differentiation in two prescription drug markets : staff report to the Federal Trade Commission / by Ronald S. Bond and David F. Lean [Bureau of Economics]. ([Washington : For sale by the Supt. of Docs., U.S. Govt. Print. Off.], 1977), by Ronald S. Bond (page images at HathiTrust)
• Competitive problems in the drug industry summary and analysis / [by Glenn R. Markus]. (Washington : U.S. Govt. Print. Off., 1972), by Library of Congress. Education and Public Welfare Division (page images at HathiTrust)
• FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1997), by Natural Resources United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth (page images at HathiTrust)
• The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2003), by United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness (page images at HathiTrust)
• Competition in the pharmaceutical marketplace : antitrust implications of patent settlements : hearing before the Committee on the Judiciary, United States Senate, One Hundred Seventh Congress, first session, May 24, 2001. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., [Congressional Sales Office], 2002), by United States Senate Committee on the Judiciary (page images at HathiTrust)
• Pay to delay : are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2010), by United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy (page images at HathiTrust)
• Preclinical and clinical testing by the pharmaceutical industry, 1979 : hearing before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session, on examination of the process of drug testing and FDA's role in the process, October 11, 1979. (Washington : U.S. Govt. Print. Off. : [For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office], 1979), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research (page images at HathiTrust)
• Polydrug abuse the response of the medical profession and the pharmaceutical industry : a report of the Select Committee on Narcotics Abuse and Control, Ninety-fifth Congress, second session. (Washington : U. S. Govt. Print. Off., 1979), by United States. Congress. House. Select Committee on Narcotics Abuse and Control (page images at HathiTrust)
• Global competitiveness of U.S. advanced-technology manufacturing industries : pharmaceuticals : report to the Committee on Finance, United States Senate, on investigation no. 332-302 under section 332(g) of the Tariff Act of 1930 (Washington, D.C. : U.S. International Trade Commission, [1991]) (page images at HathiTrust)
• Competitive problems in the drug industry psychotropic drugs : summary and analysis / Select Committee on Small Business, United States Senate ; prepared by the Congressional Research Service, Library of Congress ; [prepared by Stephanie Forbes ; edited by Vikki Zegel]. (Washington : U.S. Govt. Print. Off., 1979), by Library of Congress. Congressional Research Service (page images at HathiTrust)
• Poisons and habit-forming drugs. : A digest of laws and regulations relating to the possession, use, sale, and manufacture of poisons and habit-forming drugs enacted during 1912 and 1913, now in force in the United States. (Washington : Govt. print. off., 1913), by Martin Inventius Wilbert (page images at HathiTrust)
• Detailing by druggists, a supplement to the book Detailing the physician. For retail druggists. by Tom Jones. (New York, Romaine Pierson publishers, inc., [1942]), by Tom Jones (page images at HathiTrust)
• The Commissioner's report of investigation of charges from joint hearings, Subcommittee on Health, Labor and Public Welfare Committee, Subcommittee on Administrative Practice and Procedure, Judiciary Committee, United States Senate, August 15-16, 1974. ([Washington? : Food and Drug Administration?], 1975), by United States. Food and Drug Administration (page images at HathiTrust)
• How health care reform affects pharmaceutical research and development / The Congress of the United States, Congressional Budget Office. (Washington, D.C. : The Office, [1994]), by Anna Cook (page images at HathiTrust)
• Markets for American pharmaceutical, medicinal, and biological prepartions. (Washington : Govt. print. off., 1923), by Bureau of Foreign and Domestic Commerce (page images at HathiTrust)
• Crime in America--the heroin paraphernalia trade. Hearings, Ninety-first Congress, second session, pursuant to H. Res. 17 ... October 5 and 6, 1970. (Washington, U.S. Govt. Print. Off., 1970), by United States. Congress. House. Select Committee on Crime (page images at HathiTrust)
• Report to industry. (Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 1997), by Center for Drug Evaluation and Research (U.S.) (page images at HathiTrust)
• Retail diversion of legal drugs : a major problem with no easy solution : report to the Congress / by the Comptroller General of the United States. (Washington : General Accounting Office, 1978), by United States General Accounting Office (page images at HathiTrust)
• Report of the drug, medicine, and toilet preparations industry. ([Washington, D.C.?], 1941), by United States. Department of Labor. Wage and Hour Division (page images at HathiTrust)
• Interim reports / Review Panel on New Drug Regulation, Department of Health, Education, and Welfare. ([Washington] : The Dept., 1977), by Education United States. Department of Health (page images at HathiTrust)
• Assessment of the Commissioner's report of October 1975 / Review Panel on New Drug Regulation, Department of Health, Education, and Welfare. ([Washington] : The Department, 1976), by Education United States. Department of Health (page images at HathiTrust)
• Review Panel on New Drug Regulation : final report. (Washington : Dept. of Health, Education, and Welfare, Review Panel on New Drug Regulation, 1977), by Education United States. Department of Health (page images at HathiTrust)
• A report on the aspects of concentration and product obsolescence in the pharmaceutical industry in the United States. [Prepared by Richard D. Mannis and others] December 4, 1961. C-64195-2. ([Cambridge, Mass. : [s.n.], 1961]), by Inc Arthur D. Little (page images at HathiTrust)
• The drug story; a factological history of America's $10,000,000,000 drug cartel -- its methods, operations, hidden ownership, profits and terrific impact on the health of the American people. (Washington, Columbia Pub. Co., [1949]), by Morris Allison Bealle (page images at HathiTrust)
• The generic drug maze : speeding access to affordable life-saving drugs : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, July 20, 2006. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2006), by United States. Congress. Senate. Special Committee on Aging (page images at HathiTrust)

More items available under narrower terms.